Synthesis and evaluation of in vitro antitubercular activity and antimicrobial activity of some novel 4H-chromeno[2,3-d]pyrimidine via 2-amino-4-phenyl-4H-chromene-3-carbonitriles

Agarwal A, Srinivas K, Puri SK, Chauhan PMS (2005) Synthesis of 2, 4, 6-trisubstituted pyrimidines as antimalarial agents. Bioorg Med Chem 13:4645–4650

Ali A, Taylor GE, Ellsworth K, Harris G, Painter R, Silver LL, Young K (2003) Novel pyrazolo[3, 4-d]pyrimidine-Based Inhibitors of staphlococcus aureus dna polymerase iii: design, synthesis, and biological evaluation. J Med Chem 46:1824–1830

Bedair AH, Emam HA, El-Hady NA, Ahmed K, El-Agrody AM (2001) Synthesis and antimicrobial activities of novel naphtho[2, 1-b]pyran, pyrano[2, 3-d]pyrimidine and pyrano[3, 2-e][1, 2, 4]triazolo[2, 3-c]-pyrimidine derivatives. Farmaco 56(12):965–973

Bonsignore L, Loy G, Secci D, Calignano A (1993) Synthesis and pharmacological activity of 2-oxo-(2H) 1-benzopyran-3-carboxamide derivatives. Eur J Med Chem 28:517–520

Chu TW, Plattner JJ, Katz L (1996) New directions in antibacterial research. J Med Chem 36:3853–3871

Collee JG, Duguid JP, Fraser AG, Marmion BP, (eds) (1989) Mackie and Mccartney practical medicinal microbiology, 13th edn. Churchill Livingstone, Edinburgh, p 87

Dell CP, Williams AC (1995) pyrano[3,2-H]quinolines for treating restenosis. USP 5434160

Doshi JM, Tian D, Xing C (2007) Ethyl-2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H- chromene-3-carboxylate (HA 14–1), a prototype small-molecule antagonist against antiapoptotic bcl-2 proteins, decomposes to generate reactive oxygen species that induce apoptosis. Mol Pharm 30:919–928

Dye C, Scheele S, Dolin R, Pathania V, Raviglione M (1999) Global burden of tuberculosis. J Am Med Assoc 282:677–686

Eid FA, Abd El-Wahab AHF, El-Hag Ali GAM, Khafagy MM (2004) Synthesis and antimicrobial evaluation of naphtho[2, 1-b]pyrano[2, 3-d]pyrimidine and pyrano[3, 2-e][1, 2, 4]triazolo[1, 5-c]pyrimidine derivatives. Acta Pharma 54:13–26

Ellis GP (1977) The chemistry of heterocyclic compounds. In: Weissberger A, Tailor EC (eds) Chromenes, chromanes and chromones. John Wiley, New York

Espinal MA (2003) The global situation of MDR-TB. Tuberculosis 83:44–51

Francis JS, Doherty MC, Lopatin U, Johnston CP, Sinha G, Ross T, Cai M, Hanse NN, Per T, Ticehurst JR, Carroll K, Thomas DL, Nuermberger E, Barlett JG (2005) Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. Clin Infect Dis 40:100–107

Frieden TH, Sterling TH, Munsiff SS, Watt CJ, Dye C (2003) Tuberculosis. Lancet 362:887–899

Gangjee A, Mavandadi F, Sherry F, Queener SF (1997) Effect of N9-methylation and bridge atom variation on the activity of 5-substituted 2, 4-diaminopyrrolo[2, 3-d]pyrimidines against dihydrofolate reductases from pneumocystis carinii and toxoplasma gondii. J Med Chem 40:1173–1177

Green GR, Evans JM, Vong A (1995) Comprehensive heterocyclic chemistry. Pergamon Press, Oxford

Hoult JRS, Moroney MA, Paya M (1994) Actions of flavonoids and coumarins on lipoxygenase and cyclooxygenase. Methods Enzymol 234:443–545

Katiyar SB, Bansal I, Saxena JK, Chauhan PMS (2005) Syntheses of 2, 4, 6-trisubstituted pyrimidine derivatives as a new class of antifilarial topoisomerase II inhibitors. Bioorg Med Chem Lett 15:47–50

Kruszewska D, Sahl HG, Bierbaum G, Pag U, Hynes SO, Ljungh AJ (2004) Mersacidin eradicates methicillin-resistant Staphylococcus aureus (MRSA) in a mouse rhinitis mode. Antimicrob Chemother 54:648–653

Ohnishi H, Kosuzume H, Suzuki Yasuo, Mochida T, (1982) 7-Diethylamino-5-methyl-thiazolo[5,4-d]pyrimidine and pharmaceutical composition containing same USP 4476127

Pietta PG (2000) Flavonoids as Antioxidants. J Nat Prod 63:1035–1042

Ren Q, Cui Z, He H, Gu Y (2007) A facile synthesis and fungicidal activities of novel fluorine-containing pyrido[4, 3-d]pyrimidin-4(3H)-ones. J Fluorine Chem 128:1369–1375

Roberto B, Giovanna B, Maria LC, Raimondo M, Alessandro M, Paolo R, Giovanni S (2001) Three-component process for the synthesis of 2-amino-2-chromenes in aqueous media. Tetrahedron 57:1395–1398

Saudi MNS, Gaafar MR, El-Azzouni MZ, Ibrahim MA, Eissa MM (2008) Synthesis and evaluation of some pyrimidine analogs against toxoplasmosis. Med Chem Res 17:541–563

Siddiqi S (1992) Clinical microbiology handbook. ASM Press, Washington, D.C

Smith P, Moss A (1994) Epidemiology of tuberculosis. B Bloom, Washington, D.C

Stocks PA, Raynes KJ, Bray PG, Park BK, Neill PM, Ward SA (2002) Novel short chain chloroquine analogues retain activity against chloroquine resistant k1 plasmodium falciparum. J Med Chem 45:4975–4983

Sunduru N, Agawal A, Katiyar S, Nishi B, Goyal N, Gupta S, Chauhan PMS (2006) Synthesis of 2, 4, 6-trisubstituted pyrimidine and triazine heterocycles as antileishmanial agents. Bioorg Med Chem 14:7706–7715

Torrence PF, Fan X, Zhang X, Loiseau PM (2006) Structurally diverse 5-substituted pyrimidine nucleosides as inhibitors of Leishmania donovani promastigotes in vitro. Bioorg Med Chem Lett 16:5047–5051

Tuberculosis Facts (2009) World Health Organization. http://www.who.int/tb/publications/2009/tbfactsheet_2009update_one_page.pdf